February 9, 2026
1 min read

Fresenius Kabi, Phlow ink US onshoring alliance to boost epinephrine injection supply

The agreement will see Phlow as the first drugmaker to produce epinephrine injection API in the U.S., while Fresenius will work on formulation and finished doses to ship to U.S. hospitals and clinics, the companies said.

Leave a Reply

Your email address will not be published.

Previous Story

dsm-firmenich completes consumer pivot with €2.2B Animal Nutrition divestment

Next Story

Water-Damaged Homes, Heavy Air Pollution Increase Asthma Risk In Kids MedNews

Previous Story

dsm-firmenich completes consumer pivot with €2.2B Animal Nutrition divestment

Next Story

Water-Damaged Homes, Heavy Air Pollution Increase Asthma Risk In Kids MedNews

Latest from Blog

Go toTop